By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Pieris 

Blumenstraße 16

Freising-Weihenstephan    85354  Germany
Phone: 49-0-8161-71-389 Fax: 49-0-8161-71-3484


SEARCH JOBS


Industry
Pharmaceutical






Company News
Pieris Achieves Milestone Payment In Daiichi Sankyo, Inc. (4568.t) Collaboration To Develop Anticalin® Therapeutics 6/23/2014 8:51:22 AM
Pieris Achieves Fourth Milestone Payment In Daiichi Sankyo, Inc. (4568.t) Collaboration To Develop Anticalin® Therapeutics 1/13/2014 7:53:14 AM
Pieris Receives Third Milestone Payment In Daiichi Sankyo, Inc. (4568.t) Collaboration To Develop Anticalin® Therapeutics 11/12/2013 7:02:45 AM
Zydus Cadila and Pieris Sign Broad Co-Development Alliance for Novel Anticalin® Therapeutics 10/16/2013 10:06:06 AM
Pieris and Sanofi (France) (SAN.PA) Broaden Existing Collaboration 4/10/2013 11:37:20 AM
Pieris Presents Data and Reveals Targets for Anticalin® Bispecific PRS-190 at European Antibody Congress 11/29/2012 9:46:50 AM
Pieris Achieves First Milestone Payment in Daiichi Sankyo, Inc. (4568.t) Collaboration to Develop Anticalin® Therapeutics 10/9/2012 11:01:37 AM
Pieris Presents Preclinical Data for PRS-110 c-Met Antagonist Anticalin® at the American Association for Cancer Research Annual Meeting 4/4/2012 9:52:40 AM
Pieris Receives BMBF Grant to Fund PRS-110c-Met Antagonist Anticalin(R) Program 2/7/2012 9:56:05 AM
Pieris Presents Preclinical Data for PRS-080 Hepcidin Antagonist Anticalin(R) Program at American Society of Hematology Annual Meeting 12/13/2011 10:21:31 AM
1234
//-->